Resources search

Neglected tropical diseases : hidden successes, emerging opportunities

World Health Organization [WHO]
2006

Expand view

This report looks at neglected tropical diseases. These diseases particularly affect poor and disadvantaged people with limited access to health services and have a low profile and status in public health priorities. Despite the challenges involved, some progress has been made through interventions around particular diseases in certain countries. This report highlights some of those successes

Global strategy for further reducing the leprosy burden and sustaining leprosy control activities 2006-2010 : operational guidelines

WORLD HEALTH ORGANIZATION (WHO) : REGIONAL OFFICE FOR SOUTH-EAST ASIA
2006

Expand view

The purpose of these guidelines is to help managers of national health services to implement the new Global Strategy in their own countries. They will help managers to choose which activities can be carried out at the primary health care level and for which aspects of care patients will have to be referred. They suggest a greater emphasis on the assessment of disability at diagnosis, so that those at particular risk can be recognised and managed appropriately. They also cover prevention of disability, rehabilitation, recording and reporting and programme management. The French version of the guidelines is an unofficial translation

Report of the second meeting of the Global Alliance to eliminate lymphatic filariasis

GLOBAL ALLIANCE TO ELIMINATE LYMPHATIC FILARIASIS
2002

Expand view

This meeting was an opportunity for Global Alliance members to take stock of activities related to lymphatic filariasis (LF) elimination programmes at country, regional and global levels. This report aims to capture the basic elements of the discussion at the meeting. The aim was to enable the Alliance to build on progress to date and scale up coverage to ensure that by 2020 LF is eliminated. It is a useful resource for health managers

Vaccines and Biologicals biennial report 00/01

WORLD HEALTH ORGANIZATION (WHO). Department of Vaccines and Biologicals
2002

Expand view

This report highlights the achievements of the Vaccines and Biologicals Department of the World Health Organization (WHO). In particular it highlights the formation of the Global Alliance for Vaccines and Immunization, the drop in the number of polio cases, the lack of progress in the research and development field, and the lack of access that over 37 million children still have to immunization services. In the light of these findings it lists where its efforts will focused in the future. These include facilitating and coordinating research and development activities on vaccines against diseases of poverty; strengthening routine immunization services and vaccine-preventable disease surveillance; identifying and implementing long-term financial sustainability mechanisms; certifying the world as polio-free and addressing post-eradication technical challenges;and accelerating efforts to control diseases and reduce vaccine-preventable mortality through supplemental immunicsation activities

Elimination of leprosy as a public health problem : progress and prospects

NOORDEEN, S K
1995

Expand view

Leprosy is still an important problem in about 80 countries of Asia, Africa and Latin America, some 2.4 million persons being estimated to have the disease in 1994. The WHO-recommended standard multidrug therapy (MDT) was introduced in the 1980s and has been shown to be effective in combating the disease. Experiences based on many thousands of patients treated with MDT over the past decade indicate extremely low relapse rates (cumulative relaps rates around 1 percent). By the end of 1993, some 5.6 million patients had been cured, and the global cumulative MDT coverage of registrered patients had reached 89 percent. The number of registrered cases fell from 5.4 million in 1985 to 1.7 million in 1994. The significant progress made in leprosy control enabled the World Health Assembly in 1991 to set a goal for eliminating leprosy as a public health problem by the year 2000. One important epidemiological factor is that leprosy is very unevenly distributed: 80 percent of the problem is confined to only five countries and 92 percent to just 25 countries. The elimination strategy envisages identifying and treating with MDT a total of about 5 million cases from 1994 to the year 2000. The cost of dealing with these cases has been estimated at US$ 420 million, including US$ 150 million for the drugs.

Pages

E-bulletin